Cos. Say Rival Got Confidential Docs In Diabetes Drug MDL
Drugmakers including Eli Lilly & Co. argued Tuesday that the plaintiffs in multidistrict litigation over the alleged pancreatic risks of their diabetes drugs had violated a confidentiality order by showing confidential...To view the full article, register now.
Already a subscriber? Click here to view full article